TG and spindle cell hemangioma: Further research is needed to guide the development of clinical care models for targeting early diagnosis and treatment and to determine whether thyroid hormone replacement would be beneficial for CCF patients with SCH, to both further reduce mortality and morbidity and improve quality of care in these patients.